The independent source for health policy research, polling, and news.
261-280 of 396 results
The Community Oncology Alliance is targeting the prescription drug provisions of the Build Back Better Act, saying they will trigger deep cuts in oncologistsâ pay, causing clinics to close and health care costs to rise. But it leaves out some important details.
Experts weigh in as the federal government urges everyone to get boosted amid concerns over omicron, a new covid variant.
A Supreme Court majority appears ready to overturn nearly 50 years of abortion rights, at least judging by the latest round of oral arguments before the justices. And a new covid variant, omicron, gains attention as it spreads around the world. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet and Shefali Luthra of The 19th join KHNâs Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Blake Farmer of Nashville Public Radio about the latest KHN-NPR âBill of the Monthâ episode.
The PAWS for Veterans Therapy Act means more veterans with symptoms of traumatic stress can get specially trained service dogs.
The Republican senator says President Joe Bidenâs âinflation crisisâ caused Medicare to raise monthly premiums, which will add hundreds of dollars to beneficiariesâ costs. But Medicare experts say inflation was not to blame and most beneficiaries will shoulder a much smaller increase than what Rick Scott claims.
President Joe Bidenâs social spending budget is on its way to the U.S. Senate, where Democratic leaders are (optimistically) hoping to complete work by the end of the year. Meanwhile, covid is surging again in parts of the country, along with the political divides it continues to cause. Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and the Johns Hopkins School of Public Health, and Mary Agnes Carey of KHN join KHNâs Julie Rovner to discuss these issues and more. Also this week, Rovner previews next weekâs Supreme Court abortion oral arguments with Florida State University law professor Mary Ziegler.
You probably wonât be testing everyone at your Thanksgiving table for covid because the tests are expensive and hard to find. Why? The federal government is partly to blame.
But state and local officials embrace the requirement because it creates a safer workplace while allowing employees to continue working.
Federal health officials appear poised to extend a recommendation for covid boosters to all adults, following moves by some governors and mayors to broaden the eligible booster pool as caseloads rise. Meanwhile, the Food and Drug Administration finally has a nominee to head the agency: former FDA chief Robert Califf. And Medicare premiums for consumers will likely rise substantially in 2022, partly due to the approval of a controversial drug to treat Alzheimerâs disease. Tami Luhby of CNN, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHNâs Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dan Weissmann, host of the âAn Arm and a Legâ podcast.
Congress last year shielded consumers from unexpected out-of-network charges, but hospitals and doctors have decried the arbitration plan put forward by the Biden administration for negotiating these bills as favoring insurers. More than 150 members of the House agree.
Congress is making slow progress toward completing its ambitious social spending bill, although its Thanksgiving deadline looks optimistic. Meanwhile, a new survey finds the average cost of an employer-provided family plan has risen to more than $22,000. Thatâs about the cost of a new Toyota Corolla. Alice Miranda Ollstein of Politico, Anna Edney of Bloomberg News and Rebecca Adams of CQ Roll Call join KHNâs Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Rebecca Love, a nurse academic and entrepreneur, about the impending crisis in nursing.
The infrastructure bill passed Friday funnels $15 billion into lead pipe remediation. Water quality experts say the cost of getting rid of all lead pipes could ultimately cost $60 billion. Still, some health advocates say the new funding will be transformative in allowing communities such as Houstonâs Fifth Ward to fix its pipes.
A last-minute agreement among lawmakers restored a provision seeking to hold down rising costs of prescription medicines. Although details on which drugs will be targeted remain sketchy, the legislation would help patients buying insulin and cap Medicare beneficiariesâ out-of-pocket drug costs at $2,000 a year.
KHN answers questions for seniors about how this new benefit might work.
The latest iteration of President Joe Biden's social-spending package would close the health insurance gap for at least 2.2 million people, making a huge difference especially in the South, where political opposition has blocked Medicaid expansion.
Some front-line workers who die of covid-19 have been considered eligible for accidental death benefits because it is presumed their infection was contracted on the job. But some employers now suggest that if the workers didnât follow established safety protocols, such as getting vaccinated, those benefits may be denied.
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Hereâs a collection of their appearances.
Health equity advocates see a once-in-a-generation opportunity to provide a dental benefit to millions of older Americans as Congress considers expanding Medicare services. But complicating that push is a debate over how many of the more than 60 million Medicare recipients should receive dental coverage.
President Joe Biden unveiled a compromise âBuild Back Betterâ framework shortly before taking off for key meetings in Europe, but itâs unclear whether the framework can win the votes of all Democrats in the House and Senate, and it leaves out some of the partyâs health priorities, notably significant provisions to lower prescription drug prices. Meanwhile, younger children may soon be eligible for covid vaccines. Joanne Kenen of Politico and Johns Hopkins, Sarah Karlin-Smith of the Pink Sheet and Rachana Pradhan of KHN join KHNâs Julie Rovner to discuss these issues and more.
Negotiations on the health parts of President Joe Bidenâs domestic agenda are getting serious but have yet to produce a deal every Democrat can support. Meanwhile, the Food and Drug Administration remains without a nominated leader but manages to take the first steps toward approving over-the-counter hearing aids. Joanne Kenen of Politico and Johns Hopkins, Tami Luhby of CNN and Rachel Cohrs of Stat join KHNâs Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read too.
Š 2026 KFF